BNTC
Benitec Biopharma Ltd
11.00$
+0.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.2% | 97.5% | 97.8% | 97.9% | 97.5% | 92.0% | 96.4% | 80.7% | 83.5% | 99.0% | 98.9% | 99.5% | |
| 85.4% | 91.7% | 76.7% | 75.4% | 81.7% | 83.5% | 92.5% | 68.0% | 55.5% | 97.4% | 98.1% | 98.5% | |
| 85.4% | 91.8% | 76.7% | 75.5% | 81.7% | 83.5% | 92.5% | 68.0% | 55.5% | 97.4% | 98.1% | 98.5% | |
| 1.2% | 8.2% | 15.4% | 19.9% | 19.1% | 0.5% | 0.1% | 0.1% | 1.2% | 0.4% | 0.0% | – | |
| 8.2% | 0.6% | -0.3% | 0.0% | 0.0% | 8.1% | – | 0.0% | 0.3% | 0.1% | – | – | |
| 1.4% | 2.5% | 2.0% | 1.5% | 1.7% | 6.5% | 2.7% | 16.6% | 13.7% | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 4.9% | 5.3% | 3.9% | 12.2% | 9.6% | 12.8% | 6.4% | 51.7% | 95.5% | 9.5% | 2.3% | 3.1% | |
| 4.9% | 5.2% | 3.8% | 11.9% | 9.6% | 9.7% | 6.4% | 42.4% | 89.1% | 9.4% | 1.8% | 2.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.6% | 1.0% | 4.2% | 6.2% | 0.5% | 0.4% | 0.3% | |
| 2.3% | 2.0% | 0.6% | 2.0% | 5.4% | 2.4% | 1.3% | 7.1% | 25.5% | 2.6% | 0.2% | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 70.9% | 70.8% | 94.9% | 64.2% | 60.2% | 87.2% | 93.6% | 48.3% | 4.5% | 90.5% | 97.7% | 96.9% | |
| -320.2% | -494.0% | -598.9% | -502.9% | -395.7% | -993.2% | -608.6% | -2,483.3% | -3,761.0% | -364.4% | -229.1% | -149.9% | |
| 0.4% | 0.6% | 0.6% | 0.8% | 0.7% | 2.0% | 4.7% | 32.2% | 31.0% | 19.7% | 36.4% | 25.5% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.